The Process Development Blog

Strong CMC outcomes depend on deep process development. Learn how a science-first approach ensures reproducibility, scalability, and successful tech transfer.

APC experts explain process portability: how science and digitalisation help pharmaceutical companies reliably transfer manufacturing processes across global sites.

APC and VLE mark Rare Disease Day 2024 by reaffirming their commitment to accelerating therapeutics for conditions where only 5% have approved treatments.

Process portability - the ability to transfer manufacturing seamlessly across facilities - is the foundation of pharmaceutical supply chain resilience in an unstable environment.

This case study highlights the significance of particle size analysis via Dynamic Light Scattering (DLS) in the development of vaccines based on the MVA virus.

APC & VLE Therapeutics, the Irish Multinational group, announce €100M expansion and 300 new jobs to establish ‘The Medicine Accelerator Campus’ in Cherrywood, Dublin

APC's vision for CMC medicine acceleration combines scientific excellence with full digitalisation and radical collaboration to navigate the tightrope of drug development.

APC's webinar covers novel HPAPI development strategies using digital twins, PAT, and continuous processing to cut development time and cost for highly potent APIs.

We’re delighted to announce that APC has received Deloitte's 'Ireland's Best Managed Company Award' at a gala in Dublin on September 14, 2023. This award is given based on a company's overall success, including its company culture, management strength, capacity for innovation, strategic initiatives, sustainability, and financial performance.